| BIOARCTIC AB B |
| Schweden |
| Gesundheit |
| SE0010323311 / A2H5GS |
| B9A (Frankfurt) |
| FRA:B9A, ETR:B9A, B9A:GR |
| - |
| https://www.bioarctic.se/ |
|
BioArctic AB (publ) is a Swedish research-based biopharmaceutical company specializing in disease-modifying treatments for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. Founded in 2003 by Professor Lars Lannfelt and Dr. PÃ..
>Volltext.. |
| 2724.11 Mio. EUR |
| 2526.47 Mio. EUR |
| 187.39 Mio. EUR |
| - |
| 95.83 Mio. EUR |
| 1.08 EUR |
| 4.13 Mio. EUR |
| 97.52 Mio. EUR |
| 134.14 Mio. EUR |
| 4.21 |
| 723.13% |
| - |
| - |
| - |
| - |
| 10.05.19 - 0.13599€ |
| - |
| BIOARCTIC |
| 05.04.26 |
|